Infinity Pharmaceuticals Inc (INFI)

Add to Watchlists

Create an Alert

Quickflows

3.04 -0.14 -4.40% NASDAQ Feb 26, 16:59 USD

Infinity Pharmaceuticals News

Wire

Headline

Time (ET)
Yahoo

Your 2 Best Profit Opportunities in 2021

02/20 07:40
SA Breaking News

Piper Sandler initiates Infinity Pharmaceuticals at overweight

02/18 15:39
Yahoo

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021

02/18 10:02
Yahoo

Infinity Announces Closing of $92 Million Public Offering of Common Stock

02/18 08:30
MT Newswires

--Analyst Actions: Piper Sandler Starts Infinity Pharmaceuticals at Overweight with $7 Price Target

02/18 08:15
MT Newswires

Infinity Pharmaceuticals Prices Common Stock Offering at $3.80 Per Share

02/12 10:51
SA Breaking News

Infinity slips 8% on capital raise

02/12 09:11
Yahoo

Infinity Announces Pricing of $80 Million Public Offering of Common Stock

02/12 08:30
Yahoo

The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed

02/12 08:10
MT Newswires

--Analyst Actions: B. Riley Adjusts Infinity Pharmaceuticals' Price Target to $8 From $4.50, Keeps Buy Rating

02/12 08:03
MT Newswires

Infinity Pharmaceuticals Plans Share Offering -- Stock Up 7% After-Hours

02/11 17:46
Yahoo

Infinity Announces Proposed Public Offering of Common Stock

02/11 16:01
Yahoo

Why Infinity Pharmaceuticals Is Skyrocketing Today

02/11 12:38
PR Newswire

Thinking about buying stock in Seelos Therapeutics, Celsion Corp, Zosano Pharma, Outlook Therapeutics, or Infinity Pharmaceuticals?

02/11 09:31
Yahoo

Infinity Pharmaceuticals to Present at Upcoming BIO CEO & Investor Conference

02/11 09:25
Yahoo

Infinity Pharma Shows Encouraging Eganelisib/Nivolumab Combo Data In Urothelial Cancer Study

02/11 09:16
SA Breaking News

SNDL, OGI, MVIS and SONO among premarket gainers

02/11 08:27
SA Breaking News

Infinity Pharma gains on encouraging eganelisib + nivolumab data in urothelial cancer trial

02/11 08:02
Yahoo

Infinity Pharmaceuticals Presents Data from Randomized, Placebo-Controlled, Phase 2 MARIO-275 Trial of Eganelisib and Nivolumab in Advanced Urothelial Cancer at ASCO Genitourinary Cancers Symposium

02/11 07:15
Yahoo

Infinity Pharmaceuticals Announces Conference Call for the ASCO Genitourinary Cancers Symposium to Discuss Clinical Data from MARIO-275 Phase 2 Study

02/10 16:05

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.